Indian Drug Company To Copy Roche Flu Drug

Law360, New York (October 14, 2005, 12:00 AM EDT) -- In the midst of a global panic over a possible bird flu pandemic, an Indian drug company has decided to produce a generic version of Roche Pharmaceuticals’ Tamiflu treatment without permission from the patent holder.

Indian drug maker Cipla said it would initiate production of the drug regardless of whether Roche grants the company a license.

"Right or wrong, we are going to commercialize and make Oseltamivir," Yusuf K. Hamied, chairman of Mumbai-based Cipla, told The New York Times. Oseltamivir is the drug’s generic name....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.